Mr. Etienne Grima reports

CARDIOCOMM SOLUTIONS APPOINTS NEW BOARD MEMBER AND PROVIDES CORPORATE UPDATE

Cardiocomm Solutions Inc. has added Dr. Robin Black to its board of directors. In addition, the company would like to provide an update on its audit of its financial statements for the year ended Dec. 31, 2023.

The company confirms that Dr. Black has joined as the fourth member of its board of directors. Dr. Black brings a wealth of experience in the development and support of early-stage medical device company technologies. During his time with the National Research Council (NRC), Dr. Black co-founded the NRC space life science program with a special focus on the application of Canada's expertise in telemedicine to the design of the health care facility on the international space station. He subsequently served as an industrial technology adviser with NRC's industrial research assistance program, working under a mandate to support the development of medical device companies nationally. Throughout his career, he has been active in supporting the engineering profession through the executive of affiliate organizations of the Engineering Institute of Canada and presently serves on the executive of the Vancouver Island Engineering Society. Dr. Black received a BSc in biology from McMaster University, a BASc in mechanical engineering from Queens University and a PhD in biomedical engineering from the University of Strathclyde, and holds a certified clinical engineer (CCE) designation.

In January of 2024, Cardiocomm undertook a comprehensive review of its financial reporting and accounting infrastructure and pro-actively implemented system changes that included engaging a professional advisory firm to oversee audit functions and financial operations. These changes will ensure the company will continue to meet its reporting timelines, starting with the company's 2023 year-end financial statements and associated disclosures, due April 29, 2024, in addition to improving the quality of the information disseminated to the company's valued shareholders. The adviser will also provide the company with access to a range of consulting, accounting and advisory services. The contracted firm has extensive experience with ASPE (accounting standards for private enterprises), IFRS (international financial reporting standards) and U.S. GAAP (generally accepted accounting principles), and a variety of securities filings such as prospectuses, registration statements, business acquisition reports and other public filings in the United States and Canada, and has assisted companies in going-public transactions through CPCs (capital pool companies) and reverse takeovers, as well as assisting with buy-side and sell-side due diligence.

About Cardiocomm Solutions

Cardiocomm Solutions Inc.'s patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. Cardiocomm Solutions has earned the ISO 13485 and ISO 27001 certifications, is HIPAA compliant, and holds medical device clearances and sales licences from the U.S. (the U.S. Food and Drug Administration) and Canada (Health Canada).

We seek Safe Harbor.